远程医疗公司促FDA合法化肽类
2026-07-23 14:13:22
据彭博社报道，包括Hims & Hers Health Inc.和Noom Inc.在内的远程医疗公司敦促专家小组建议将几种热门肽类合法化，同时呼吁加强监管并建立不良反应报告系统。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Binance 与 STOP THE TRAFFIK 建立合作，联手打击人口贩运相关金融流动Next article：
AI趋势 | SemiAnalysis：看好ASML营收预期
